Vice President, Head of Clinical Pharmacology, Pfizer Oncology Division
Pfizer, California, United States
Donghua Yin, PhD is currently Vice President and Head of Clinical Pharmacology, Pfizer Oncology Division. He has more than 20 years of experience in developing small molecules and biologics drug candidates, mainly in the oncology area. His main expertise is on pharmacokinetics and pharmacodynamics, and their applications in facilitating efficient and quantitative drug development. He has authored over 100 scientific publications and conference presentations, and is co-inventor of 10 US patents. He also serves as Adjunct Clinical Professor at the College of Pharmacy, University of Michigan. He received his PhD in Pharmaceutics from The University of Tennessee Health Science Center and completed post-doctoral training at the Ohio State University.
Disclosure(s): Pfizer Inc: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Emerging New Therapeutic Modalities
Sunday, November 10, 2024
1:45 PM – 3:00 PM MST
Model-Informed Drug Development Applications to Oncology Bispecifics and Antibody-Drug Conjugates
Sunday, November 10, 2024
2:10 PM – 2:35 PM MST